Progress in the treatment of lower extremity arteriosclerosis obliterans with intracavitary volume reduction
10.3760/cma.j.issn.1673-4203.2019.11.015
- VernacularTitle: 下肢动脉硬化闭塞症的腔内减容治疗进展
- Author:
Tuerxun TUERHONG
1
;
Sheng GUAN
2
Author Information
1. Postgraduate College of Xinjiang Medical University, Urumqi 830054, China
2. Department of Vascular Surgery, People′s Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001, China
- Collective Name:Department of Vascular Surgery, People′s Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001, China
- Publication Type:Review
- Keywords:
Arteriosclerosis;
Arterial occlusive diseases;
Therapeutic uses;
Intracavitary volume reduction
- From:
International Journal of Surgery
2019;46(11):784-787
- CountryChina
- Language:Chinese
-
Abstract:
Arteriosclerosis obliterans(ASO) of lower limbs is a common vascular disease in clinic. The main treatment methods of ASO include medical treatment, surgical treatment and endovascular treatment. Endovascular therapy has been widely used in clinical treatment because of its small trauma and rapid recovery. Endovascular therapy includes percutaneous transluminal angioplasty and intraluminal volume reduction. Intravascular volume reduction has become the focus of the development of endovascular therapy. It is a prerequisite for the treatment of ASO to master various intraluminal therapy methods. This article focuses on the progress of intracavitary volume reduction therapy in ASO.
